Providence Wealth Advisors, LLC Seres Therapeutics, Inc. Transaction History
Providence Wealth Advisors, LLC
- $131 Million
- Q1 2025
A detailed history of Providence Wealth Advisors, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Providence Wealth Advisors, LLC holds 105,000 shares of MCRB stock, worth $1.53 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
105,000
Previous 105,000
-0.0%
Holding current value
$1.53 Million
Previous $87,000
16.09%
% of portfolio
0.06%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding MCRB
# of Institutions
59Shares Held
38.3MCall Options Held
103KPut Options Held
53K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$336 Million6.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$88.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$25.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.62MShares$23.5 Million0.0% of portfolio
-
Ubs Group Ag1.46MShares$21.2 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $1.8B
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...